Ketamine for Older Adults Pilot
Precision Medicine With Ketamine for Older Adults With Treatment-resistant Depression: Pilot Study
Sponsor: Washington University School of Medicine
Listed as NCT04504175, this PHASE4 trial focuses on Geriatric Depression and Late Life Depression and remains completed. Sponsored by Washington University School of Medicine, it has been updated 12 times since 2020, reflecting substantial change activity. Mental health research at this phase helps define safety and dosing parameters for future study.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Mar 2023 — Jul 2024 [monthly]
Completed PHASE4
-
May 2022 — Mar 2023 [monthly]
Completed PHASE4
Status: Active Not Recruiting → Completed
▶ Show 7 earlier versions
-
Mar 2022 — May 2022 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
-
Dec 2021 — Mar 2022 [monthly]
Recruiting PHASE4
-
Sep 2021 — Dec 2021 [monthly]
Recruiting PHASE4
-
May 2021 — Sep 2021 [monthly]
Recruiting PHASE4
-
Jan 2021 — May 2021 [monthly]
Recruiting PHASE4
-
Dec 2020 — Jan 2021 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Sep 2020 — Dec 2020 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Washington University School of Medicine
For direct contact, visit the study record on ClinicalTrials.gov .